The Russian Direct Investment Fund (RDIF) commented on the situation around the supply of domestic vaccine against Sputnik V coronavirus to Argentina.
Earlier, the newspaper La Naсion wrote, citing a letter from CeciliaNiccolini,adviser to the president of Argentina , to RDIF that in July Argentina had not received 5.5 million doses of the first component of Sputnik V and 13.1 million doses of the second component. She said the contract with Russia was in danger of being terminated, noting that other suppliers were meeting their obligations.
Later, a presidential spokesman said that the RDIF is in contact with the contractor in order to regulate the problems that arise. He described the supply situation as "not a disruption, but a delay" and added that "the top priority is to meet the vaccination needs of Russians.
“RDIF welcomes the announcement by Argentina's health minister that the workwork under the contract to supply the Russian vaccine Sputnik V"The RDIF welcomes the Argentine health minister's statement that work under the contract for the supply of the Russian vaccine Sputnik V is continuing and that there are no plans to renegotiate or cancel it. Positive experience of using Sputnik V"The positive experience with the use of Sputnik V in Argentina demonstrated exceptional safety and efficiency of the Russian vaccine, which is already produced in Argentina and is one of the most popular vaccines against new coronavirus infection," - said in the RDIF statement.
The fund added that it is actively working to continue uninterrupted supplies of Sputnik V”.
Made in Russia // Made in Russia
Author: Ksenia Gustova